You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

evolocumab

Showing 1 - 25 of 142
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rosuvastatin and Evolocumab for Coronary Artery Disease

Completed
  • Coronary Artery Disease
  • New York, New York
    Mount Sinai Hospital
Aug 2, 2023

Ischemic Stroke, Acute Trial (Evolocumab)

Not yet recruiting
  • Ischemic Stroke, Acute
  • Evolocumab
  • (no location specified)
Jan 15, 2023

Acute Metabolic Effects of Evolocumab and Atorvastatin Trial (Evolocumab)

Not yet recruiting
  • Acute Metabolic Effects of Evolocumab and Atorvastatin
  • Evolocumab
  • (no location specified)
Nov 16, 2023

Abdominal Aortic Aneurysm Trial (Evolocumab, Placebo)

Not yet recruiting
  • Abdominal Aortic Aneurysm
  • Evolocumab
  • Placebo
  • (no location specified)
Oct 12, 2023

Heart Transplant Trial in Omaha (Evolocumab (Repatha))

Active, not recruiting
  • Heart Transplant
  • Evolocumab (Repatha)
  • Omaha, Nebraska
    University of Nebraska Medical Center
Dec 15, 2022

Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis Trial in Nanjing (Evolocumab, Atorvastatin)

Not yet recruiting
  • Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis
  • Nanjing, Jiangsu, China
    the First affiliated hospital of Nanjing Medical University
Feb 14, 2023

In-stent Restenosis, Major Adverse Cardiovascular Events Trial in Beijing (PCSK9 inhibitor, Statin)

Recruiting
  • In-stent Restenosis
  • Major Adverse Cardiovascular Events
  • Beijing, Beijing, China
    Beijing Anzhen Hospital
Jan 16, 2023

Acute Coronary Syndrome Trial in Baltimore (Evolocumab, Placebos)

Active, not recruiting
  • Acute Coronary Syndrome
  • Evolocumab
  • Placebos
  • Baltimore, Maryland
    The Johns Hopkins Hospital
Dec 8, 2022

Cerebral Atherosclerosis Trial (Evolocumab 140 MG/ML, Intensive statin treatment)

Not yet recruiting
  • Cerebral Atherosclerosis
  • Evolocumab 140 MG/ML
  • Intensive statin treatment
  • (no location specified)
Oct 15, 2022

Diabetes, Type 2, Dyslipidemia Associated With Type II Diabetes, Percutaneous Coronary Intervention Trial in Falls Church

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • +2 more
  • Evolocumab
  • Placebo
  • Falls Church, Virginia
    Inova Fairfax Hospital
Dec 22, 2022

ST Elevation Myocardial Infarction Trial in Bucheon (Repatha®)

Recruiting
  • ST Elevation Myocardial Infarction
  • Bucheon, Korea, Republic of
    Sejong General Hospital
Oct 10, 2023

ST Elevation Myocardial Infarction (STEMI) Trial (Rosuvastatin 20 mg, Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA])

Not yet recruiting
  • ST Elevation Myocardial Infarction (STEMI)
  • Rosuvastatin 20 mg
  • Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA]
  • (no location specified)
Feb 1, 2023

Carotid Artery Stenosis Trial in London (Evolocumab Auto-Injector [Repatha], Placebo Auto-Injector)

Active, not recruiting
  • Carotid Artery Stenosis
  • Evolocumab Auto-Injector [Repatha]
  • Placebo Auto-Injector
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Oct 12, 2022

Malignant Glioma, Glioblastoma Trial in Durham (Evolocumab)

Recruiting
  • Malignant Glioma
  • Glioblastoma
  • Evolocumab
  • Durham, North Carolina
    Duke University Medical Center
Oct 13, 2022

Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia Trial in Yongin (Evolocumab 140 MG/ML, Rosuvastatin 5mg, Ezetimibe 10mg)

Recruiting
  • Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia
  • Evolocumab 140 MG/ML
  • +2 more
  • Yongin, Gyeonggi-do, Korea, Republic of
    Yongcheol Kim
Jan 6, 2023

Hyperlipidemia, Mixed Dyslipidemia Trial in Denver (Evolocumab)

Completed
Has Results
  • Hyperlipidemia
  • Mixed Dyslipidemia
  • Evolocumab
  • Denver, Colorado
    Research Site
Nov 3, 2022

Chronic Kidney Diseases, High Cholesterol Trial in Mineola, New York (Evolocumab, Placebo)

Withdrawn
  • Chronic Kidney Diseases
  • High Cholesterol
  • Evolocumab
  • Placebo
  • Mineola, New York
  • +1 more
Jul 27, 2022

Heart Failure With Reduced Ejection Fraction Trial in Badalona, Sevilla, Valencia (Evolocumab)

Completed
  • Heart Failure With Reduced Ejection Fraction
  • Evolocumab
  • Badalona, Barcelona, Spain
  • +2 more
Aug 10, 2022

Ticagrelor and Aspirin in Acute Coronary Syndrome

Recruiting
  • Acute Coronary Syndrome
  • Evolocumab
  • Harbin, Heilongjiang, China
    the first affiliated hospital of Harbin Medical University
Jun 9, 2022

Hyperlipidemias Trial in Boston (Evolocumab, Statins (Cardiovascular Agents))

Recruiting
  • Hyperlipidemias
  • Evolocumab
  • Statins (Cardiovascular Agents)
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 18, 2022

PCSK9 Inhibitor in Patients With Acute Ischemic Stroke

Not yet recruiting
  • Acute Ischemic Stroke
  • (no location specified)
Nov 14, 2023

Carotid Artery Stenosis, Asymptomatic Carotid Artery Stenosis Trial in North York, Toronto (Evolocumab)

Recruiting
  • Carotid Artery Stenosis
  • Asymptomatic Carotid Artery Stenosis
  • Evolocumab
  • North York, Ontario, Canada
  • +2 more
Apr 29, 2022

Atherosclerotic Vascular Disease, Type2 Diabetes, Microvascular Dysfunction Trial in New York, Toronto (Placebo, Evolocumab)

Completed
  • Atherosclerotic Vascular Disease
  • +2 more
  • Placebo
  • Evolocumab
  • New York, New York
  • +1 more
Jul 11, 2022

Hypercholesterolemia, Cardiovascular Diseases Trial in Cincinnati (lerodalcibep, evolocumab, alirocumab)

Active, not recruiting
  • Hypercholesterolemia
  • Cardiovascular Diseases
  • lerodalcibep
  • +2 more
  • Cincinnati, Ohio
  • +2 more
Jul 13, 2022

Lung Cancer Metastatic Trial in Durham (Nivolumab, Ipilimumab, Evolocumab)

Recruiting
  • Lung Cancer Metastatic
  • Durham, North Carolina
    Duke Univ. Medical Center
May 16, 2022